SelectQuote (NYSE:SLQT - Get Free Report) is set to announce its earnings results before the market opens on Monday, November 4th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. SelectQuote has set its FY 2025 guidance at EPS.Investors interested in participating in the company's conference call can do so using this link.
SelectQuote (NYSE:SLQT - Get Free Report) last released its quarterly earnings data on Friday, September 13th. The company reported ($0.18) earnings per share for the quarter. The business had revenue of $307.21 million during the quarter. SelectQuote had a negative return on equity of 10.37% and a negative net margin of 2.58%. On average, analysts expect SelectQuote to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
SelectQuote Price Performance
Shares of NYSE SLQT traded up $0.03 during mid-day trading on Monday, reaching $2.03. The company's stock had a trading volume of 1,004,194 shares, compared to its average volume of 1,016,910. The firm has a market capitalization of $348.06 million, a PE ratio of -9.71 and a beta of 1.05. The company has a debt-to-equity ratio of 2.01, a current ratio of 6.84 and a quick ratio of 6.84. The stock has a fifty day moving average of $2.67 and a two-hundred day moving average of $2.81. SelectQuote has a 52 week low of $1.03 and a 52 week high of $4.46.
Analyst Ratings Changes
Separately, Craig Hallum started coverage on SelectQuote in a research report on Monday, September 30th. They issued a "buy" rating and a $4.50 target price on the stock.
View Our Latest Stock Analysis on SLQT
About SelectQuote
(
Get Free Report)
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Featured Stories
Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
